We’re confident in our future
Our bold ambitions for patients are reflected in our commitments to a step-change in growth and performance over the period to 2026. This means more GSK vaccines and medicines, including innovative new products, will reach more people than ever before.
Speeches and presentations
42nd annual JP Morgan Healthcare ConferenceListen to the webcast
Emma Walmsley, Chief Executive Officer, participated in the 42nd annual JP Morgan Healthcare Conference on Tuesday 9 January at 07:30-08:10am PST / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.
Getting ahead of Respiratory Diseases with GSK managementWatch the recording
GSK management held a virtual event on 30 November at 8:00 AM EST / 1:00 PM GMT. The event featured a presentation and an interactive Q&A session. A replay is available on demand.
Evercore ISI HealthCONx ConferenceListen to the webcast
Phil Dormitzer, SVP and Global Head Vaccines R&D and Infectious Disease Research, discussed the progress being made in vaccine innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, 29 November 2023, 12:30pm UK / 7:30am ET.
Getting ahead of HIV with ViiV Healthcare managementWatch the recording
ViiV Healthcare management held a virtual event on 28 September at 9:00 AM EDT / 2:00 PM BST. The event, "Getting ahead of HIV," featured a presentation and an interactive Q&A. A recording of the session is available on YouTube.